
Biotechnology
New patent for the endocrine drug Abbvie LUPRON DEPOT-PED KIT – DrugPatentWatch
Copyright © DrugPatentWatch. Originally published in New patent for the endocrine drug Abbvie LUPRON DEPOT-PED KIT
Annual Drug Patent Expiration for LUPRON+DEPOT-PED+KIT
Lupron Depot-ped Kit is a drug marketed by Abbvie Endocrine Inc and included in one NDA. It is available from a single supplier.
The generic ingredient in the LUPRON DEPOT-PED KIT is leuprolide acetate. One registered supplier for this compound. Additional details are available on the leuprolide acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the endocrine drug Abbvie LUPRON DEPOT-PED KIT